Daily Market Updates: Big biopharma increasingly looks to China for new drugs

Global Markets

Home›Global Markets›China›Big biopharma increasingly looks to China for new drugs

Big biopharma increasingly looks to China for new drugs

Reported · Written up by our desk · China

CNBC World reports that Western biopharma companies are turning to China to source new drug innovation as a major patent cliff approaches.

The outlet says the shift is being driven by expectations that patents held by pharma firms will expire over the coming period, pushing companies to pursue multibillion-dollar deals tied to new pipelines.

← Newer storyBitcoin reverses early gains after soft U.S. jobs data Older story →UK average diesel price tops £2 a litre as fuel costs rise

More like this

Global MarketsCXMT makes progress on new memory chip designs

Global MarketsNearly 180 lift entrapments reported after voltage dip in Hong Kong

Global MarketsChinese stocks look undervalued, Himalaya Capital chairman says

Global MarketsChina Mobile triples capacity at Hohhot AI computing hub

Global MarketsRevamped Huanggang Port opens in Shenzhen, drawing early crowds

Sources

CNBC WorldBig Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

Global Markets

Big biopharma increasingly looks to China for new drugs

More like this

Sources

Get the close, explained.